The anesthesiologist and assistant professor at the university, Nizamuddin Mithagi, referring to the 4-fold increase in the price of blood sugar test strips in Iran, said that reducing the access of diabetics to these strips makes it difficult to control blood sugar levels and regulate treatment, and may increase the risk of serious complications such as kidney damage, brain problems and heart disease.
He also referred to the lack of transparency in the importation, production and distribution of drugs in the Islamic Republic as one of the factors that could exacerbate the shortage of equipment and drugs.